Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4621 to 4635 of 8211 results

  1. Frequency of monitoring:- What is the effectiveness of more frequent monitoring compared with monitoring at 12 months after diagnosis in people with newly diagnosed coeliac disease?

    Recommendation ID NG20/5 Question Frequency of monitoring:- What is the effectiveness of more frequent monitoring compared with monitoring

    Research recommendation
    Published
    13 October 2015

  2. Frequency of monitoring:- What is the long-term cost effectiveness, in terms of patient-relevant outcomes including bestcorrected visual acuity and quality of life, of different review frequencies/strategies for people at risk of progression to late AMD (wet active)?

    Recommendation ID NG82/4 Question Frequency of monitoring:- What is the long-term cost effectiveness, in terms of patient-relevant outcomes

    Research recommendation
    Published
    13 November 2018

  3. Frequency of review: What is the most clinical and cost-effective frequency of review for children and young people with CKD?

    Recommendation ID NG203/12 Question Frequency of review: What is the most clinical and cost-effective frequency of review for children

    Research recommendation
    Published
    30 September 2021

  4. Fresh frozen plasma for patients with abnormal haemostasis who are having invasive procedures or surgery:- What dose of fresh frozen plasma is most clinically effective at preventing bleeding in patients with abnormal haemostasis who are having invasive procedures or surgery?

    Recommendation ID NG24/4 Question Fresh frozen plasma for patients with abnormal haemostasis who are having invasive procedures or surgery:-

    Research recommendation
    Published
    11 December 2015

  5. Needs assessment: From the perspective of everyone involved, what is the acceptability of strengths and rights-based approaches to social work assessment and what are the barriers and facilitators to delivering these?

    Recommendation ID NG216/01 Question Needs assessment: From the perspective of everyone involved, what is the acceptability of strengths

    Research recommendation
    Published
    1 June 2022

  6. Risk assessment: From the perspective of everyone involved, what works well and could be improved about the use of tools and checklists to support social work risk assessment for people with complex needs?

    Recommendation ID NG216/02 Question Risk assessment: From the perspective of everyone involved, what works well and could be improved about

    Research recommendation
    Published
    1 June 2022

  7. In infants, children and young people with overt or occult reflux, is fundoplication effective in reducing acid reflux as determined by oesophageal pH monitoring?

    Recommendation ID NG1/3 Question In infants, children and young people with overt or occult reflux, is fundoplication effective in reducing

    Research recommendation
    Published
    15 November 2019

  8. Further collection of quality of life data from people who are cured and who have experience of amputation and chemotherapy are also needed. Additional data on the health effects on parents, siblings and others with life-threatening illness would also be of value.

    Recommendation ID TA235/2 Question Further collection of quality of life data from people who are cured and who have experience of amputation

    Research recommendation
    Published
    9 June 2015

  9. For people with alcohol dependence, which medication is most likely to improve adherence and thereby promote abstinence and prevent relapse?

    Recommendation ID CG115/6 Question For people with alcohol dependence, which medication is most likely to improve adherence and thereby

    Research recommendation
    Published
    9 June 2015

  10. Antiplatelet therapy: For people with CKD at the highest risk of cardiovascular disease, what is the clinical effectiveness of low-dose aspirin compared with placebo for primary prevention of cardiovascular disease?

    Recommendation ID NG203/19 Question Antiplatelet therapy: For people with CKD at the highest risk of cardiovascular disease, what is the

    Research recommendation
    Published
    30 September 2021

  11. Duration of thyroid stimulating hormone suppression: For people with differentiated thyroid cancer who have had surgery and radioactive iodine (RAI), what is the optimal duration of thyroid stimulating hormone suppression?

    Recommendation ID NG230/04 Question Duration of thyroid stimulating hormone suppression: For people with differentiated thyroid cancer

    Research recommendation
    Published
    6 January 2023

  12. Imaging for further staging: For people with differentiated thyroid cancer who have initial ultrasound evidence of extensive local spread (T2N1), what is the clinical and cost effectiveness of CT, MRI or F-18 FDG PET-CT scanning, with or without ultrasound, as part of a further staging strategy?

    Recommendation ID NG230/07 Question Imaging for further staging: For people with differentiated thyroid cancer who have initial ultrasound

    Research recommendation
    Published
    6 January 2023

  13. For people with favourable aneurysm morphology needing an EVAR as a primary procedure, evidence on the safety of using endoanchoring systems is adequate. However, evidence on efficacy is inadequate in quantity and quality. Therefore, for these people, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    Recommendation ID IPG725/02 Question For people with favourable aneurysm morphology needing an EVAR as a primary procedure, evidence on

    Research recommendation
    Published
    1 June 2022

  14. For people with generalised anxiety disorder (GAD) who are ready to start a low-intensity intervention, what is the clinical effectiveness of physical activity compared with waiting-list control?

    Recommendation ID CG113/3 Question For people with generalised anxiety disorder (GAD) who are ready to start a low-intensity intervention

    Research recommendation
    Published
    9 June 2015

  15. Thyroid peroxidase antibody testing: For people with indeterminate cytopathology, what is the clinical and cost effectiveness of thyroid peroxidase antibody testing?

    Recommendation ID NG230/06 Question Thyroid peroxidase antibody testing: For people with indeterminate cytopathology, what is the clinical

    Research recommendation
    Published
    6 January 2023